Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q1

2372.TEDINET S100RJUD
Period2023-04-01 → 2023-06-30
Filed2023-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥4.7bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥18.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥4.8bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥737m2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥1.4bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥1.1bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥3.3bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.4bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥1.2bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥891m2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.5bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥891m2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥36.1bnat 2023-06-30Cons.Assets
Total assets¥35.1bnat 2023-03-31Cons.Assets
Total assets¥28.2bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥23.3bnat 2023-06-30Cons.Liabilities
Total liabilities¥23.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥12.8bnat 2023-06-30Cons.Net assets
Net assets / equity¥12.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥11.0bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥8.5bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥9.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥73.662023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥88.372022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥210.062022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥88.222022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio35.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio38.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-06-30¥86m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-06-30¥70m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-06-30¥15m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30−¥212m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥774m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥774m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥328m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2023-04-01 → 2023-06-30¥875m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥269m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2023-04-01 → 2023-06-30¥190m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2023-04-01 → 2023-06-30¥1.6bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2023-04-01 → 2023-06-30¥1.4bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥137m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2023-04-01 → 2023-06-30¥36m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2023-04-01 → 2023-06-30¥453m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2023-04-01 → 2023-06-30¥277m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥176m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2023-04-01 → 2023-06-30−¥49m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2023-04-01 → 2023-06-30¥2.5bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2023-04-01 → 2023-06-30¥2.3bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥174m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.1bn
—segment totalrevenue2023-04-01 → 2023-06-30¥5.3bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥4.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥758m
—segment totalsegment profit2023-04-01 → 2023-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥5.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥4.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥774m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥45m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥364m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2022-04-01 → 2022-06-30¥370m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥359m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥10m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2022-04-01 → 2022-06-30¥40m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥75m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-06-30¥61m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥483m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥256m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥226m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥38m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥24m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥337m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥357m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 402
ItemContextValueUnit
Number of shares held in own name treasury shares etcCurrentQuarterInstant230800
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant230800
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0187
Cash and depositsPrior1YearInstant9386000000JPY
Cash and depositsCurrentQuarterInstant8488000000JPY
Accounts receivable tradePrior1YearInstant3389000000JPY
Accounts receivable tradeCurrentQuarterInstant3469000000JPY
Merchandise and finished goodsPrior1YearInstant80000000JPY
Merchandise and finished goodsCurrentQuarterInstant76000000JPY
Work in processPrior1YearInstant345000000JPY
Work in processCurrentQuarterInstant372000000JPY
Raw materials and suppliesPrior1YearInstant387000000JPY
Raw materials and suppliesCurrentQuarterInstant374000000JPY
Short term loans receivablePrior1YearInstant689000000JPY
Short term loans receivableCurrentQuarterInstant673000000JPY
Other caPrior1YearInstant1448000000JPY
Other caCurrentQuarterInstant1672000000JPY
Allowance for doubtful accounts caPrior1YearInstant-398000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-399000000JPY
Current assetsPrior1YearInstant15328000000JPY
Current assetsCurrentQuarterInstant14728000000JPY
Buildings and structures netPrior1YearInstant7191000000JPY
Buildings and structures netCurrentQuarterInstant7272000000JPY
Tools furniture and fixtures netPrior1YearInstant1274000000JPY
Tools furniture and fixtures netCurrentQuarterInstant1510000000JPY
Machinery equipment and vehicles netPrior1YearInstant1059000000JPY
Machinery equipment and vehicles netCurrentQuarterInstant1039000000JPY
LandPrior1YearInstant1272000000JPY
LandCurrentQuarterInstant1943000000JPY
Construction in progressPrior1YearInstant2206000000JPY
Construction in progressCurrentQuarterInstant2295000000JPY
Property plant and equipmentPrior1YearInstant13003000000JPY
Property plant and equipmentCurrentQuarterInstant14061000000JPY
GoodwillPrior1YearInstant915000000JPY
GoodwillCurrentQuarterInstant920000000JPY
Other iaPrior1YearInstant44000000JPY
Other iaCurrentQuarterInstant51000000JPY
Intangible assetsPrior1YearInstant959000000JPY
Intangible assetsCurrentQuarterInstant972000000JPY
Investment securitiesPrior1YearInstant2959000000JPY
Investment securitiesCurrentQuarterInstant3238000000JPY
Long term loans receivablePrior1YearInstant542000000JPY
Long term loans receivableCurrentQuarterInstant631000000JPY
Guarantee deposits ioaPrior1YearInstant1426000000JPY
Guarantee deposits ioaCurrentQuarterInstant1397000000JPY
Deferred tax assetsPrior1YearInstant114000000JPY
Deferred tax assetsCurrentQuarterInstant49000000JPY
Other ioaPrior1YearInstant794000000JPY
Other ioaCurrentQuarterInstant994000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass